Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa

被引:7
|
作者
Kussmann, Manuel [1 ]
Hauer, Stefan [1 ]
Pichler, Petra [2 ]
Reznicek, Gottfried [3 ]
Burgmann, Heinz [1 ]
Poeppl, Wolfgang [1 ,4 ]
Zeitlinger, Markus [5 ]
Wiesholzer, Martin [2 ]
机构
[1] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Internal Med 1, Vienna, Austria
[2] Karl Landsteiner Univ Hlth Sci, Univ Hosp St Poelten, Dept Internal Med 1, St Polten, Austria
[3] Univ Vienna, Dept Pharmacognosy, Vienna, Austria
[4] Austrian Armed Forces, Mil Med Cluster East, Vienna, Austria
[5] Med Univ Vienna, Dept Clin Pharmacol, Waehringerguertel 18-20, A-1090 Vienna, Austria
关键词
Antibiotics; Infection; Peritoneal dialysis solutions; Peritonitis; Time-kill curves; INTRAVENOUS FOSFOMYCIN; ANTIBIOTICS; INTRAPERITONEAL; CIPROFLOXACIN; DAPTOMYCIN; ERTAPENEM; OUTCOMES; PH;
D O I
10.1007/s10096-018-3221-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Peritonitis is still the main infectious complication among patients on peritoneal dialysis. For treatment of peritoneal dialysis-related peritonitis, the intraperitoneal administration of antibiotics admixed to peritoneal dialysis fluids (PDFs) should be preferred. However, the influence of diverse PDFs on the activity of frequently used antibiotics has been investigated insufficiently. Thus, the present study set out to investigate the in vitro activity of fosfomycin against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus epidermidis, and Staphylococcus aureus in commercially available PDFs. Time-kill curves in four different PDFs (DianealA (R), ExtranealA (R), NutrinealA (R), and PhysionealA (R)) were performed over 24 h with two different concentrations of fosfomycin (150 and 400 mg/L) and without antibiotics as control. Cation-adjusted Mueller Hinton broth (CA-MHB) was used as a comparator solution. In blank PDFs, bacterial growth of each organism evaluated was reduced when compared to CA-MHB. For S. aureus in blank PhysionealA (R), a reduction under the limit of detection was observed within 24 h. The activity of fosfomycin was reduced in all PDFs when compared to CA-MHB except for P. aeruginosa in NutrinealA (R) where the activity of fosfomycin was increased when investigated at 400 mg/L. Against E.coli, bactericidal activity was demonstrated in ExtranealA (R), NutrinealA (R), and PhysionealA (R). Fosfomycin resistance (MIC > 1024 mg/L) was observed for P. aeruginosa in CA-MHB at both concentrations and in NutrinealA (R) at 150 mg/L. Fosfomycin is active in PDFs particularly against the frequently isolated enterobacterium E. coli. The choice of the respective PDF considerably influences the microbiological outcome in vitro. Further studies are warranted to investigate the clinical relevance of these findings.
引用
收藏
页码:1091 / 1098
页数:8
相关论文
共 50 条
  • [1] Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa
    Manuel Kussmann
    Stefan Hauer
    Petra Pichler
    Gottfried Reznicek
    Heinz Burgmann
    Wolfgang Poeppl
    Markus Zeitlinger
    Martin Wiesholzer
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1091 - 1098
  • [2] Antibacterial activity of herbal infusions against Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa in vitro
    Volodymyr Zazharskyi
    Pavlo Davydenko
    Oleg Kulishenko
    Iryna Borovik
    Viktor Brygadyrenko
    Nadiia Zazharska
    MAGYAR ALLATORVOSOK LAPJA, 2019, 141 (11) : 693 - 704
  • [3] Antibacterial activity of turmeric extract against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa
    Zahid, Israa Mahdi
    Al-Qaraghuli, Noor Hassoon
    Neama, Noor A.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 : 509 - 513
  • [4] In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus
    Robinson, Duane A.
    Griffith, Ronald W.
    Shechtman, Dan
    Evans, Richard B.
    Conzemius, Michael G.
    ACTA BIOMATERIALIA, 2010, 6 (05) : 1869 - 1877
  • [5] Ingestion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli by human peritoneal mesothelial cells
    Visser, CE
    BrouwerSteenbergen, JJE
    SchadeeEestermans, IL
    Meijer, S
    Krediet, RT
    Beelen, RHJ
    INFECTION AND IMMUNITY, 1996, 64 (08) : 3425 - 3428
  • [6] Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa
    El-Sukhon, SN
    Boukhatem, ZF
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (06) : 613 - 617
  • [7] THE INFLUENCE OF DIFFERENT CULTURE MEDIA ON Pseudomonas aeruginosa, Escherichia coli, AND Staphylococcus aureus BIOFILM FORMATION
    Soares Lopes, Leonardo Quintana
    Guerim, Pedro
    Vianna Santos, Roberto Christ
    Marquezan, Flavia Kolling
    Marquezan, Patricia Kolling
    BIOSCIENCE JOURNAL, 2023, 39
  • [8] Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli
    Piddock, LJV
    Jin, YF
    Ricci, V
    Asuquo, AE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) : 61 - 70
  • [9] In vitro activity of gemifloxacin and five other fluoroquinolones against defined isogenic mutants of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus
    Schulte, A
    Heisig, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 1037 - 1038
  • [10] Comparison of the bactericidal activity of moxifloxacin and levofloxacin against staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae
    Lemmen, SW
    Häfner, H
    Klik, S
    Lütticken, R
    Zolldann, D
    CHEMOTHERAPY, 2003, 49 (1-2) : 33 - 35